Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery.

Détails

Ressource 1Télécharger: 26929630_BIB_11858A30CE14.pdf (1732.64 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_11858A30CE14
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery.
Périodique
Therapeutics and clinical risk management
Auteur⸱e⸱s
Tsilimbaris M.K., Tsika C., Kymionis G.D.
ISSN
1176-6336 (Print)
ISSN-L
1176-6336
Statut éditorial
Publié
Date de publication
2016
Peer-reviewed
Oui
Volume
12
Pages
177-182
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
To report two cases of chronic postoperative cystoid macular edema, resistant to topical therapy, treated with consecutive intravitreal injections of ketorolac tromethamine.
Four daily intravitreal injections of 500 μg/0.05 mL of ketorolac were given to each patient. Complete clinical examination and OCT were performed before every injection, 1, 2, 3 weeks, and 1, 3, and 6 months after the last injection. Fluorescein angiography was performed at baseline examination, 1, 3, and 6 months after the last injection.
In both cases, the edema regressed and visual acuity increased. At 6 months after the last injection, the leakage was significantly reduced at the fluorescein angiography.
Both cases responded favorably to the consecutive intravitreal administration of ketorolac tromethamine. The long-lasting remission of the macular edema in these chronic cases underlines the therapeutic potential of these agents when delivered intravitreally.
Mots-clé
NSAIDs, intravitreal, ketorolac, postoperative CME
Pubmed
Web of science
Open Access
Oui
Création de la notice
30/09/2019 16:57
Dernière modification de la notice
15/01/2021 8:08
Données d'usage